Company Filing History:
1 out of 3,604 
1 out of 13 Years Active: 2022
Title: Ongpipattanakul Boonsri: Innovator in Endothelin-Converting Enzyme Inhibitors
Introduction
Ongpipattanakul Boonsri is a notable inventor based in Bangkok, Thailand. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit endothelin-converting enzymes. His work has implications for both skin whitening and antihypertensive treatments.
Latest Patents
Ongpipattanakul Boonsri holds a patent for an endothelin-converting enzyme inhibitor. This innovative material is designed to inhibit the activity of endothelin-converting enzymes, making it effective for skin whitening and managing hypertension. The active ingredient in his patent includes at least one component selected from a group of extracts known for their beneficial properties.
Career Highlights
Throughout his career, Ongpipattanakul has worked with prominent organizations such as Kao Corporation and Chulalongkorn University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Ongpipattanakul has collaborated with esteemed colleagues, including Hiroshi Hashimoto and Mitsuyuki Hotta. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Ongpipattanakul Boonsri is a distinguished inventor whose work in endothelin-converting enzyme inhibitors showcases his commitment to advancing medical science. His contributions have the potential to improve health outcomes in various applications.